PDS BiotechnologyPDSB
13F holders, Q1 2025 (March 31)48holders −4
9new positions
12sold out
1famous investor
$1.19avg. 13F price*
At the end of Q1 2025, 48 institutions reported holding PDS Biotechnology Corp. (PDSB) in their 13F filings, down 4 from Q4 2024. 9 opened new positions and 12 sold out. The largest holders were Armistice Capital, LLC ($5.3M), Vanguard Group Inc. ($1.8M) and BlackRock, Inc. ($581K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- PDS Biotechnology Corp.
- CUSIP
- 70465T107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $5.4M |
| Exits | 12 | $969K |
All 13F filers, Q4 2024 → Q1 2025: 4,924,988 shares bought and 936,165 shares sold, net +3,988,823 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Armistice Capital, LLC | 0.14% | New | 4,419,000 | $5.3M |
| Vanguard Group Inc. | 0.00% | Add +0.3% | 1,510,221 | $1.8M |
| BlackRock, Inc. | 0.00% | Reduce -6.7% | 488,033 | $581K |
| Geode Capital Management, LLC | 0.00% | Add +5.0% | 437,881 | $521K |
| Blair William & Co. | 0.00% | Add +63.3% | 257,200 | $306K |
| UBS Group AG | 0.00% | Add +401.7% | 251,156 | $299K |
| State Street Corp. | 0.00% | No change | 133,333 | $159K |
| Commonwealth Equity Services, LLC | 0.00% | Add +18.4% | 92,030 | $110K |
| Northern Trust Corp. | 0.00% | No change | 82,532 | $98K |
| Inspirion Wealth Advisors, LLC | 0.01% | Add +2.5% | 75,382 | $90K |
| Iron Gate Global Advisors LLC | 0.01% | New | 75,016 | $89K |
| Millennium Management | 0.00% | Reduce -60.0% | 50,625 | $60K |
| Bank of New York Mellon Corp | 0.00% | Reduce -0.0% | 29,293 | $35K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 28,523 | $34K |
| Bank of America Corp. | 0.00% | Add +0.1% | 26,954 | $32K |
| Susquehanna International Group, LLP | 0.00% | Reduce -89.6% | 25,753 | $31K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 24,900 | $30K |
| Ritholtz Wealth Management | 0.00% | New | 19,659 | $23K |
| Tempus Wealth Planning, LLC | 0.01% | No change | 18,800 | $22K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +36.2% | 18,800 | $22K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -0.0% | 18,382 | $22K |
| Morgan Stanley | 0.00% | Reduce -3.2% | 17,315 | $21K |
| Wealth Group, Ltd. | 0.01% | No change | 15,399 | $18K |
| First Manhattan Co. Llc. | 0.00% | New | 15,000 | $18K |
| Marex Group Ltd | 0.00% | No change | 14,000 | $17K |
| Raymond James Financial Inc. | 0.00% | Reduce -12.0% | 13,965 | $17K |
| Sandbox Financial Partners, LLC | 0.01% | New | 12,666 | $15K |
| Mercer Global Advisors Inc. | 0.00% | No change | 12,500 | $15K |
| Burns J W & Co. Inc. | 0.00% | No change | 10,300 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +85.2% | 9,361 | $11K |
| Simplex Trading, LLC | 0.00% | Reduce -4.5% | 7,898 | $9K |
| Kathleen S. Wright Associates Inc. | 0.00% | No change | 7,000 | $8K |
| Wells Fargo & Company | 0.00% | Add +10.3% | 5,329 | $6K |
| Blue Trust, Inc. | 0.00% | No change | 4,500 | $5K |
| Creative Financial Designs Inc. | 0.00% | No change | 3,000 | $4K |
| FMR LLC | 0.00% | Add +228.0% | 2,778 | $3K |
| BNP Paribas Financial Markets | 0.00% | Reduce -7.9% | 1,138 | $1K |
| Truvestments Capital LLC | 0.00% | No change | 1,111 | $1K |
| Bessemer Group Inc. | 0.00% | No change | 1,146 | $1K |
| Hughes Financial Services, LLC | 0.00% | New | 764 | $825 |
| JPMorgan Chase & Co. | 0.00% | No change | 619 | $737 |
| Osaic Holdings, Inc. | 0.00% | Reduce -90.9% | 500 | $595 |
| Rise Advisors, LLC | 0.00% | New | 325 | $387 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 257 | $306 |
| SBI Securities Co., Ltd. | 0.00% | No change | 106 | $126 |
| National Bank of Canada | 0.00% | No change | 1 | $1 |
| Caitong International Asset Management Co., Ltd | 0.00% | Reduce -99.6% | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -80.7% | 288 | $0 |
"% of holder's portfolio" is PDSB's weight in each manager's 13F, not the share of PDS Biotechnology Corp. the manager owns.